Loading provider…
Loading provider…
Neurology Physician in Chicago, IL
NPI: 1295712545Primary Practice Location
RUSH UNIVERSITY MEDICAL CENTER
1620 W Harrison St, Chicago, IL
Primary Employer
Rush University Internists
rush.edu
HQ Phone
Get MD Aikaterini's Phone NumberMobile
Get MD Aikaterini's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
IL State Medical License
1993 - 2026

American Board of Psychiatry and Neurology
Neurology
Rush University Medical Center
Residency • Neurology
1995 - 1998
McGaw Medical Center of Northwestern University
Residency • Neurology
1992 - 1995
Ascension Illinois/Saint Francis
Residency • Internal Medicine
1990 - 1992
University of Patras School of Medicine
Medical School
Until 1988
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 145 | 220 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 89 | 123 |
| 3 | 95874Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | 65 | 160 |
| 4 | 64616Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | 45 | 118 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 27 | 27 |
Human T-cell lymphotropic virus type 1-associated myelopathy, Sjögren syndrome, and lymphocytic pneumonitis.
Authors: Blondell Gage
H reflex in S-1 radiculopathy: latency versus amplitude controversy revisited.
Authors: Takashi Nishida, Aikaterini Kompoliti, Ian Janssen, Karen F. Levin
Publication Date: 1996-07
Lead Sponsor: AEON Biopharma, Inc.
Collaborators: PPD Development, LP
Intervention / Treatment: DRUG: Placebo, DRUG: ABP-450
Lead Sponsor: Emalex Biosciences Inc.
Intervention / Treatment: DRUG: Ecopipam
Lead Sponsor: Neurocrine Biosciences
Intervention / Treatment: DRUG: Placebo oral capsule, DRUG: Valbenazine